XML 64 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Sep. 30, 2018
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount   $ 29.1    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   3 years 2 months 4 days    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   15,584,419   12,063,560
Restricted common stock, vesting in equal monthly installments   10 years    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage   25.00%    
Aggregate Intrinsic Value, Exercised   $ 2.4    
Fair Value of Shares Vested   $ 0.7 $ 0.1  
Common stock reserved for future awards or option grants   19,640,465   15,448,012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 6.50 $ 1.57  
Restricted Stock Units [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   7,107   10,651
Equity incentive Plan 2016 and 2020 [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   16,018,660    
Equity Incentive Plan 2018 [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   6,634,333    
Equity Incentive Plans [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Description In September 2018, ARS Pharma adopted the 2018 Equity Incentive Plan. As a result of the Merger, on November 8, 2022 ARS Pharma, as the accounting acquirer, is deemed to have assumed Silverback’s 2016 and 2020 Equity Incentive Plans, and Employee Stock Purchase Plan (“ESPP”). For the three months ended March 31, 2023, ESPP activity is not material to the condensed consolidated financial statements.      
Equity Incentive Plans [Member] | Equity incentive Plan 2016 and 2020 [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   9,956,626    
Common stock reserved for future awards or option grants   3,754,826    
Equity Incentive Plans [Member] | Equity Incentive Plan 2018 [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number   5,634,900    
Common stock reserved for future awards or option grants   294,113